Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. L-leucine, L-isoleucyl-l-alpha-aspartyl-l-glutaminyl-l-glutaminyl-l-valyl-l-leucyl-l-seryl-l-arginyl-l-isoleucyl-l-lysyl-l-leucyl-l-alpha-glutamyl-l-isoleucyl-l-lysyl-l-arginyl-l-cysteinyl-, 2,2,2-trifluoroacetate (1:5)
1. Fexapotide Triflutate [usan]
2. 98lva678me
3. Nx-1207 Trifluoroacetate
4. 1609252-56-3
5. Fexapotide Triflutate (usan)
6. Unii-98lva678me
7. Chembl3707309
8. Fexapotide Triflutate [who-dd]
9. D11248
10. Ile-asp-gln-gln-val-leu-ser-arg-ile-lys-leu-glu-ile-lys-arg-cys-leu Trifluoroacetate
11. L-isoleucyl-l-alpha-aspartyl-l-glutaminyl-l-glutaminyl-l-valyl-l-leucyl-l-seryl-l-arginyl-l-isoleucyl-l-lysyl-l-leucyl-l-alpha-glutamyl-l-isoleucyl-l-lysyl-l-arginyl-l-cysteinyl-l-leucine Pentakis(2,2,2-trifluoroacetate)
12. L-leucine, L-isoleucyl-l-.alpha.-aspartyl-l-glutaminyl-l-glutaminyl-l-valyl-l-leucyl-l-seryl-l-arginyl-l-isoleucyl-l-lysyl-l-leucyl-l-.alpha.-glutamyl-l-isoleucyl-l-lysyl-l-arginyl-l-cysteinyl-, 2,2,2-trifluoroacetate (1:5)
13. L-leucine, L-isoleucyl-l-alpha-aspartyl-l-glutaminyl-l-glutaminyl-l-valyl-l-leucyl-l-seryl-l-arginyl-l-isoleucyl-l-lysyl-l-leucyl-l-alpha-glutamyl-l-isoleucyl-l-lysyl-l-arginyl-l-cysteinyl-, 2,2,2-trifluoroacetate (1:5)
| Molecular Weight | 2625.6 g/mol |
|---|---|
| Molecular Formula | C100H168F15N27O35S |
| Hydrogen Bond Donor Count | 37 |
| Hydrogen Bond Acceptor Count | 56 |
| Rotatable Bond Count | 77 |
| Exact Mass | 2625.1710886 g/mol |
| Monoisotopic Mass | 2624.1677338 g/mol |
| Topological Polar Surface Area | 1070 Ų |
| Heavy Atom Count | 178 |
| Formal Charge | 0 |
| Complexity | 4290 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 20 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 6 |
Enzyme Activators
Compounds or factors that act on a specific enzyme to increase its activity. (See all compounds classified as Enzyme Activators.)
Urological Agents
Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Fexapotide triflutate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fexapotide triflutate, including repackagers and relabelers. The FDA regulates Fexapotide triflutate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fexapotide triflutate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Fexapotide triflutate supplier is an individual or a company that provides Fexapotide triflutate active pharmaceutical ingredient (API) or Fexapotide triflutate finished formulations upon request. The Fexapotide triflutate suppliers may include Fexapotide triflutate API manufacturers, exporters, distributors and traders.
Fexapotide triflutate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fexapotide triflutate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fexapotide triflutate GMP manufacturer or Fexapotide triflutate GMP API supplier for your needs.
A Fexapotide triflutate CoA (Certificate of Analysis) is a formal document that attests to Fexapotide triflutate's compliance with Fexapotide triflutate specifications and serves as a tool for batch-level quality control.
Fexapotide triflutate CoA mostly includes findings from lab analyses of a specific batch. For each Fexapotide triflutate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fexapotide triflutate may be tested according to a variety of international standards, such as European Pharmacopoeia (Fexapotide triflutate EP), Fexapotide triflutate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fexapotide triflutate USP).
LOOKING FOR A SUPPLIER?
